Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jun;27(6):811–822. doi: 10.1111/j.1365-2125.1989.tb03444.x

The renal and haemodynamic effects of a 10 h infusion of glutamyl-L-dopa in normal man.

T M MacDonald 1, R F Jeffrey 1, M R Lee 1
PMCID: PMC1379809  PMID: 2527048

Abstract

1. gamma-L-glutamyl-L-dopa (gludopa) and placebo were given by intravenous infusion to 12 healthy salt replete men for 10 h in a single-blind randomised fashion. 2. Gludopa caused a cumulative natriuresis of 46.5 mmol compared with placebo with a biphasic pattern and this was associated with a small reduction in body weight. 3. A small fall in arterial blood pressure and rise in pulse rate was seen with gludopa. 4. Plasma renin activity, atrial natriuretic peptide and urine kallikrein excretion were unchanged by gludopa but a small fall in urine aldosterone excretion, urine flow rate and free water clearance occurred. 5. The renal effects of gludopa are modest and last for only a few hours after the start of infusion.

Full text

PDF
811

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H., SAYRE D. F. THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL. J Pharmacol Exp Ther. 1964 Sep;145:326–336. [PubMed] [Google Scholar]
  2. Al-Dujaili E. A., Edwards C. R. Development and application of a simple radioimmunoassay for urinary aldosterone. Clin Chim Acta. 1981 Nov 11;116(3):277–287. doi: 10.1016/0009-8981(81)90047-4. [DOI] [PubMed] [Google Scholar]
  3. Amundsen E., Putter J., Friberger P., Knos M., Larsbraten M., Claeson G. Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol. 1979;120A:83–95. doi: 10.1007/978-1-4757-0926-1_9. [DOI] [PubMed] [Google Scholar]
  4. Barbieri C., Caldara R., Ferrari C., Crossignani R. M., Recchia M. Inhibition of the renin-angiotensin-aldosterone system by L-dopa with and without inhibition of extracerebral dopa decarboxylase in man. Clin Sci (Lond) 1981 Aug;61(2):187–190. doi: 10.1042/cs0610187. [DOI] [PubMed] [Google Scholar]
  5. Calne D. B., Brennan J., Spiers A. S., Stern G. M. Hypotension caused by L-dopa. Br Med J. 1970 Feb 21;1(5694):474–475. doi: 10.1136/bmj.1.5694.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carey R. M., Hughes J. M. Selective renal dopamine-1 receptor stimulation in man. Clin Exp Hypertens A. 1987;9(5-6):1009–1020. doi: 10.3109/10641968709161462. [DOI] [PubMed] [Google Scholar]
  7. Da Prada M., Zürcher Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci. 1976 Oct 15;19(8):1161–1174. doi: 10.1016/0024-3205(76)90251-4. [DOI] [PubMed] [Google Scholar]
  8. Gutkowska J., Thibault G., Januszewicz P., Cantin M., Genest J. Direct radioimmunoassay of atrial natriuretic factor. Biochem Biophys Res Commun. 1984 Jul 31;122(2):593–601. doi: 10.1016/s0006-291x(84)80074-1. [DOI] [PubMed] [Google Scholar]
  9. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
  10. Jansen R. W., Penterman B. J., van Lier H. J., Hoefnagels W. H. Blood pressure reduction after oral glucose loading and its relation to age, blood pressure and insulin. Am J Cardiol. 1987 Nov 1;60(13):1087–1091. doi: 10.1016/0002-9149(87)90358-4. [DOI] [PubMed] [Google Scholar]
  11. Jeffrey R. F., MacDonald T. M., Lee M. R. A comparison of the renal actions of gamma-L-glutamyl-L-dopa and gamma-L-glutamyl-L-tyrosine in normal man. Clin Sci (Lond) 1988 Jan;74(1):37–40. doi: 10.1042/cs0740037. [DOI] [PubMed] [Google Scholar]
  12. Jeffrey R. F., MacDonald T. M., Marwick K., Lee M. R. The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man. Br J Clin Pharmacol. 1988 Feb;25(2):195–201. doi: 10.1111/j.1365-2125.1988.tb03291.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Levinson P. D., Goldstein D. S., Munson P. J., Gill J. R., Jr, Keiser H. R. Endocrine, renal, and hemodynamic responses to graded dopamine infusions in normal men. J Clin Endocrinol Metab. 1985 May;60(5):821–826. doi: 10.1210/jcem-60-5-821. [DOI] [PubMed] [Google Scholar]
  14. MacDonald T. M., Jeffrey R. F., Freestone S., Lee M. R. (+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man. Br J Clin Pharmacol. 1988 Feb;25(2):203–212. doi: 10.1111/j.1365-2125.1988.tb03292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McInnes G. T., Flores J. G., Shelton J. R., Harrison I. R., Perkins R. M., Clarke J. M. Effect of simple short term dietary control on urine electrolyte excretion in normal men. Clin Sci (Lond) 1986 Jul;71(1):125–128. doi: 10.1042/cs0710125. [DOI] [PubMed] [Google Scholar]
  16. Qamar M. I., Read A. E., Mountford R. Increased superior mesenteric artery blood flow after glucose but not lactulose ingestion. Q J Med. 1986 Sep;60(233):893–896. [PubMed] [Google Scholar]
  17. Reid I. A., Chou L., Chang D., Keil L. C. Role of dopamine in the inhibition of vasopressin secretion by L-dopa in carbidopa-treated dogs. Hypertension. 1986 Oct;8(10):890–896. doi: 10.1161/01.hyp.8.10.890. [DOI] [PubMed] [Google Scholar]
  18. Rodríguez-Iturbe B., Herrera J., García R. Relationship between glomerular filtration rate and renal blood flow at different levels of protein-induced hyperfiltration in man. Clin Sci (Lond) 1988 Jan;74(1):11–15. doi: 10.1042/cs0740011. [DOI] [PubMed] [Google Scholar]
  19. Smits J. F., Struyker-Boudier H. A. Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther. 1985 Mar;232(3):845–849. [PubMed] [Google Scholar]
  20. Worth D. P., Harvey J. N., Brown J., Lee M. R. gamma-L-Glutamyl-L-dopa is a dopamine pro-drug, relatively specific for the kidney in normal subjects. Clin Sci (Lond) 1985 Aug;69(2):207–214. doi: 10.1042/cs0690207. [DOI] [PubMed] [Google Scholar]
  21. ter Wee P. M., Rosman J. B., van der Geest S., Sluiter W. J., Donker A. J. Renal hemodynamics during separate and combined infusion of amino acids and dopamine. Kidney Int. 1986 Apr;29(4):870–874. doi: 10.1038/ki.1986.79. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES